Are you Dr. Munschauer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
100 High St
Buffalo, NY 14203Phone+1 716-859-7596Fax+1 617-679-2617
Summary
- Dr. Frederick Munschauer, MD is a board certified neurologist in Buffalo, New York. He is currently licensed to practice medicine in New York, Florida, and Maryland.
Education & Training
- Johns Hopkins UniversityResidency, Neurology, 1981 - 1984
- Johns Hopkins UniversityResidency, Internal Medicine, 1979 - 1981
- McGill University Faculty of MedicineClass of 1979
Certifications & Licensure
- NY State Medical License 1985 - 2025
- FL State Medical License 2015 - 2019
- MD State Medical License 1981 - 1985
- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 38 citationsClinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.Neeta Garg, Robert Zivadinov, Murali Ramanathan, Irene Vasiliu, Jaclyn Locke
Journal of Neuroimmunology. 2007-07-01 - 22 citationsMRI characteristics of patients with antiphospholipid syndrome and multiple sclerosisMilena Stosic, Julian L. Ambrus, Neeta Garg, Bianca Weinstock-Guttman, Murali Ramanathan
Journal of Neurology. 2010-01-01 - 8 citationsLp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple SclerosisZohara Sternberg, Alison Drake, Daniel Sternberg, Ralph H.B. Benedict, Fan Li
Journal of Clinical Immunology. 2012-01-13
Press Mentions
- Emalex Biosciences Releases Results of 12-Month Open-Label Extension Study for Tourette Syndrome CandidateOctober 6th, 2023